{"@id":"https://bioecon.ru/technology/exosome-therapies/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/exosome-therapies/","json":"https://cn.bioecon.ru/api/v1/technology/exosome-therapies/index.json"},"id":"exosome-therapies","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/kheiron-biotech/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/impacfat/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/cryoport-systems/","https://bioecon.ru/companies/umami-bioworks/","https://bioecon.ru/companies/cellmeat/","https://bioecon.ru/companies/pbs-biotech/","https://bioecon.ru/companies/spiber-technologies-ab/"]},"maturity":7,"name":"临床级治疗性外泌体与细胞外囊泡精准疗法","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"高密度中空纤维灌流反应器分泌收集"},{"n":2,"title":"工业级多级切向流超滤组合纯化"},{"n":3,"title":"表面四跨膜蛋白偶联靶向配体修饰"},{"n":4,"title":"体内促组织再生与抗炎修复确证"}],"summary":"源自间充质干细胞或工程化免疫细胞的纳米级细胞外囊泡（30-150纳米）工业级切向流规模化提取与表面修饰技术，作为无细胞再生医学药物或突破血脑屏障的高效靶向递送载体。","url":"/technology/exosome-therapies/","verified":"2026-11-22"}